Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Net Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Net Margin for 16 consecutive years, with 3.93% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin rose 2192.0% to 3.93% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.33%, a 1678.0% increase, with the full-year FY2024 number at 14.01%, down 1473.0% from a year prior.
  • Net Margin was 3.93% for Q3 2025 at Xtant Medical Holdings, down from 10.03% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 36.9% in Q3 2023 to a low of 17.98% in Q3 2024.
  • A 5-year average of 7.25% and a median of 11.58% in 2023 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: soared 5317bps in 2023, then crashed -5488bps in 2024.
  • Xtant Medical Holdings' Net Margin stood at 17.08% in 2021, then increased by 15bps to 14.47% in 2022, then dropped by -6bps to 15.31% in 2023, then surged by 35bps to 9.98% in 2024, then skyrocketed by 139bps to 3.93% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Net Margin are 3.93% (Q3 2025), 10.03% (Q2 2025), and 0.18% (Q1 2025).